Lilly’s new drugs hold steady amid the pandemic, but one migraine launch lags esagonowsky Thu, 07/30/2020 – 11:38
Category: Uncategorized
The plan sets out a new a new recruitment, retention and support package
NICE is not recommending NHS funding for Kyowa Kirin’s Poteligeo (mogamulizumab) as a treatment for mycosis fungoides or […]
Sales decline in the second quarter reflects expected disruption from COVID-19
The monoclonal antibody is the first potential passive immunisation for infants to demonstrate sustained protection across the entire […]
The scientists who developed the first 3D multicellular brain organoid with a functional blood brain barrier now report […]
A technique that maps a patient’s language centers before going into surgery works best when their brain tumor […]
Updated Date: Wed, 22 Jul 2020 00:00:00 EDT
Updated Date: Wed, 22 Jul 2020 00:00:00 EDT
